Atorvastatin calcium and Application site vesicles - a phase IV clinical study of FDA data

Summary:

Application site vesicles is reported as a side effect among people who take Atorvastatin calcium (atorvastatin calcium), especially for people who are female, 60+ old, also take Picato, and have Actinic keratosis.

The phase IV clinical study analyzes which people have Application site vesicles when taking Atorvastatin calcium. It is created by eHealthMe based on reports of 72,753 people who have side effects when taking Atorvastatin calcium from the FDA, and is updated regularly.

What is Atorvastatin calcium?

Atorvastatin calcium has active ingredients of atorvastatin calcium. It is often used in high blood cholesterol. eHealthMe is studying from 77,310 Atorvastatin calcium users. Check the latest studies of Atorvastatin calcium.

What is Application site vesicles?

Application site vesicles (small bubble within a cell at application site) is found to be associated with 270 drugs and 573 conditions by eHealthMe. Check the latest studies of Application site vesicles.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 17, 2026

72,753 people reported to have side effects when taking Atorvastatin calcium.
Among them, 21 people (0.03%) have Application site vesicles.

Could Atorvastatin calcium cause Application site vesicles?

Among these 21 people:

What is the gender of people who have Application site vesicles when taking Atorvastatin calcium? *

female: 65 %
male: 35 %

What is the age of people who have Application site vesicles when taking Atorvastatin calcium? *

What are other drugs people take besides Atorvastatin calcium? *

What are other side effects people have besides Application site vesicles? *

Application Site Erythema (redness of the skin at application site): 12 people, 57.14%
Application Site Pain: 8 people, 38.10%
Application Site Pruritus (application site severe itching of the skin): 6 people, 28.57%
Rashes (redness): 5 people, 23.81%
Application Site Reaction: 4 people, 19.05%
Application Site Swelling: 3 people, 14.29%
Application Site Discharge: 3 people, 14.29%
Application Site Irritation: 3 people, 14.29%
Application Site Burn: 3 people, 14.29%
Pain: 3 people, 14.29%

What are the existing conditions these people have? *

Actinic Keratosis (skin disease due to sun exposure): 8 people, 38.10%
Mycosis Fungoides (lymphocytes (a type of white blood cell) become malignant (cancerous) and affect the skin): 3 people, 14.29%
Acute Myocardial Infarction (acute heart attack): 2 people, 9.52%
Irritable Bowel Syndrome: 2 people, 9.52%
Depression: 2 people, 9.52%
Indigestion: 2 people, 9.52%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 4.76%
Asthma: 1 person, 4.76%
Back Disorder: 1 person, 4.76%
Back Pain: 1 person, 4.76%

* Approximation only. Some reports may have incomplete information.

Do you take Atorvastatin calcium and have Application site vesicles?

- Check whether Application site vesicles is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Atorvastatin calcium:

Atorvastatin calcium (77,310 reports)

Browse all side effects of Atorvastatin calcium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Application site vesicles:

Application site vesicles (270 drugs)

Browse all the conditions that are associated with Application site vesicles:

Application site vesicles (573 conditions)

Related publications that referenced our studies

Proti? D, Balti? S, Stupar N, Pavlov-Dolijanovi? S, Mugo?a S, Todorovi? Z, "A case of myositis with immunological background associated with statin use", Open Medicine, 2014 Oct .
Goldie MP, "Atorvastatin: a new treatment for periodontal disease?", , 2012 Jan .
Proti? D, Balti? S, Stupar N, Pavlov-Dolijanovi? S, Mugo?a S, Todorovi? Z, "A case of myositis with immunological background associated with statin use", Open Medicine, 2014 Oct .
Goldie MP, "Atorvastatin: a new treatment for periodontal disease?", , 2012 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on atorvastatin calcium (the active ingredients of Atorvastatin calcium) and Atorvastatin calcium (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.